Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Glioblastoma 12Gliosarcoma 11Central Nervous System Neoplasms 10Astrocytoma 10Brain Neoplasms 8Glioma 6Oligodendroglioma 5Optic Nerve Glioma 3Medulloblastoma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Sarcoma 2Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Sezary Syndrome 1Rectal Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Multiple Myeloma 1Melanoma 1Lymphoma, T-Cell, Cutaneous 1Liver Neoplasms 1Kidney Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 28fludarabine phosphate 26Cyclophosphamide 20Whole-Body Irradiation 17Mycophenolic Acid 17Cyclosporine 17Tacrolimus 15Busulfan 13Methotrexate 11Antilymphocyte Serum 10Radiotherapy 8Methylprednisolone 8Filgrastim 8Etoposide 8Flow Cytometry 7Bexarotene 7Vorinostat 6Bortezomib 6Psychiatric Rehabilitation 5Everolimus 5Dexamethasone 5Carboplatin 5Alemtuzumab 5hypericin 4fludarabine 4Transplantation 4Therapeutics 4Polymerase Chain Reaction 4Panobinostat 4Lenalidomide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mycosis Fungoides × O(6)-benzylguanine × Clear all
NCT00961220 2018-05-22

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

National Cancer Institute (NCI)

Phase 1/2 Completed
17 enrolled 6 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡